IntelliGenome Secures Colombian Approval for CRISPR-Based TB Test
Colombia’s National Institute for Food and Drug Surveillance has granted sanitary registration for the CRISPR-TB Blood Test, a move that signals a shift in local tuberculosis diagnostics. Houston-based IntelliGenome, the test's developer, simultaneously tapped Velez Lab as its exclusive distribution partner to roll out the technology across the country.

























